Literature DB >> 17021745

Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis.

Cinzia Azzoni1, Lorena Bottarelli, Nicoletta Campanini, Gabriella Di Cola, Giovanni Bader, Antonio Mazzeo, Carlo Salvemini, Silvia Morari, Davide Di Mauro, Enrico Donadei, Luigi Roncoroni, Cesare Bordi, Leopoldo Sarli.   

Abstract

BACKGROUND AND AIMS: Colorectal cancer (CRC) ranks as the fourth most frequently diagnosed cancer worldwide. CRCs that arise proximally or distally to the splenic flexure show differences in epidemiologic incidence, morphology, and molecular alterations, suggesting the existence of two categories of CRC based on the site of origin. The aim of the present work is to investigate the histological and molecular differences between CRCs located proximally and distally to the splenic flexure, and their potential involvement in tumor prognosis and therapeutic strategies.
METHODS: We evaluated 120 patients affected by sporadic CRC for clinicopathologic features, microsatellite instability (MSI), loss of heterozygosity (LOH) of chromosomes 18q, 8p, and 4p; they were also investigated for hMlh1, hMsh2, Fhit, p27, and Cox-2 immunostaining.
RESULTS: The mucinous histotype was more frequent in the proximal than in the distal CRCs (p<0.004). The frequency of MSI phenotype was higher in proximal than in distal tumors (p<0.001); moreover, reduced or absent hMlh1, Fhit, p27 immunohistochemical expressions were more frequent in proximal than in distal tumors (p<0.001 and 0.01 for p27). In contrast, the frequency of LOH in 18q was higher in distal than in proximal tumors (p=0.002). No significant differences were observed between proximal and distal tumors in the frequency of LOH in 8p and altered expression of hMsh2 and p53 protein.
CONCLUSION: These different features may reflect different genetic pathways of carcinogenesis and support the hypothesis of a different mechanism of cancer development between the proximal and the distal colon, with potential implications in the therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021745     DOI: 10.1007/s00384-006-0093-x

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  83 in total

Review 1.  Are there several types of colorectal carcinomas? Correlations with genetic data.

Authors:  L Martin; M Assem; F Piard
Journal:  Eur J Cancer Prev       Date:  1999-12       Impact factor: 2.497

2.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 3.  Methodology and reporting in studies of local recurrence after curative excision of the rectum for cancer.

Authors:  O F Dent; P H Chapuis; E L Bokey; R C Newland
Journal:  Br J Surg       Date:  2001-11       Impact factor: 6.939

Review 4.  Different mechanisms in the tumorigenesis of proximal and distal colon cancers.

Authors:  A Lindblom
Journal:  Curr Opin Oncol       Date:  2001-01       Impact factor: 3.645

Review 5.  The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer.

Authors:  J Tsihlias; L Kapusta; J Slingerland
Journal:  Annu Rev Med       Date:  1999       Impact factor: 13.739

6.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

Authors:  H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

7.  Allelic loss of chromosome 18q and prognosis in colorectal cancer.

Authors:  J Jen; H Kim; S Piantadosi; Z F Liu; R C Levitt; P Sistonen; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

8.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

Authors:  M Tsujii; S Kawano; R N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 9.  Are there two sides to colorectal cancer?

Authors:  Barry Iacopetta
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

10.  Sporadic colorectal cancer in elderly people.

Authors:  Shinichiro Koketsu; Toshiaki Watanabe; Tomohiro Tada; Takamitsu Kanazawa; Eiji Ueda; Hirokazu Nagawa
Journal:  Hepatogastroenterology       Date:  2003 Nov-Dec
View more
  43 in total

1.  Telomerase: a target for colorectal cancer treatment?

Authors:  Elias Kouroumalis
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.

Authors:  Herbert Thomas Maier; Felix Aigner; Birgit Trenkwalder; Matthias Zitt; Natalie Vallant; Alexander Perathoner; Christian Margreiter; Patrizia Moser; Johann Pratschke; Albert Amberger
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

3.  Is there a proximal shift in the distribution of colorectal adenomas?

Authors:  Ana Maria Freire de Oliveira; Vera Anapaz; Luís Lourenço; Catarina Graça Rodrigues; Sara Folgado Alberto; Alexandra Martins; João Ramos de Deus; Jorge Reis
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

4.  Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.

Authors:  D Wan; W Gu; G Xu; C Shen; D Ding; S Shen; S Wang; X Gong; S He; Q Zhi
Journal:  Clin Transl Oncol       Date:  2014-01-08       Impact factor: 3.405

5.  The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum.

Authors:  Kristin Wallace; Maria V Grau; Dennis Ahnen; Dale C Snover; Douglas J Robertson; Daus Mahnke; Jiang Gui; Elizabeth L Barry; Robert W Summers; Gail McKeown-Eyssen; Robert W Haile; John A Baron
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-08       Impact factor: 4.254

6.  Myeloperoxidase expression in human colonic mucosa is related to systemic oxidative balance in healthy subjects.

Authors:  Stefano Mancini; Francesco Mariani; Paola Sena; Marta Benincasa; Luca Roncucci
Journal:  Redox Rep       Date:  2017-01-09       Impact factor: 4.412

7.  Pathologic factors are more important than tumor location in long-term survival in colon cancer.

Authors:  L G J Leijssen; A M Dinaux; H Kunitake; L G Bordeianou; D L Berger
Journal:  Int J Colorectal Dis       Date:  2018-03-14       Impact factor: 2.571

8.  Survival after colorectal cancer diagnosis is associated with colorectal cancer family history.

Authors:  Jason A Zell; Jane Honda; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  Nuclear thymidylate synthase expression in sporadic colorectal cancer depends on the site of the tumor.

Authors:  Violetta Sulzyc-Bielicka; Pawel Domagala; Ewa Majdanik; Maria Chosia; Dariusz Bielicki; Jozef Kladny; Mariusz Kaczmarczyk; Krzysztof Safranow; Wenancjusz Domagala
Journal:  Virchows Arch       Date:  2009-05-15       Impact factor: 4.064

10.  Incorporating tumour pathology information into breast cancer risk prediction algorithms.

Authors:  Nasim Mavaddat; Timothy R Rebbeck; Sunil R Lakhani; Douglas F Easton; Antonis C Antoniou
Journal:  Breast Cancer Res       Date:  2010-05-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.